Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

First Horizon Receives Positive Ratings and Prepares for Barclays Global Financial Services Conference

Elaine Mendonca by Elaine Mendonca
March 8, 2024
in Breaking News
0
Investings on laptop and finances
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

Jared Shaw, an analyst at Barclays, has recently started covering First Horizon (NYSE:FHN) with an optimistic rating of Overweight and a target price of $18. This follows Citigroup’s endorsement of First Horizon with a “buy” rating and a target price of $14.00.

In other news, First Horizon Corporation is gearing up to take part in the Barclays Global Financial Services Conference. The company’s Chairman, President, and CEO, Bryan Jordan, is expected to deliver a speech on September 12, 2023.

FHN Stock Shows Positive Momentum on March 8, 2024 with Uptrend and Buying Interest

On March 8, 2024, FHN stock showed positive momentum as it traded in the middle of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been performing relatively well compared to its historical prices and is currently in an uptrend.

The price of FHN shares increased by $0.08 since the market last closed, representing a 0.53% rise. The stock opened at $15.19, which was $0.20 higher than its previous close. This suggests that there was buying interest in the stock at the opening bell, pushing the price higher right from the start of the trading day.

FHN Stock Analysis: Strong Financial Performance and Promising Growth Potential

On March 8, 2024, FHN stock showed promising performances based on the financial data provided by CNN Money. The total revenue for FHN stood at $4.78 billion for the past year, with a significant increase of 38.64% compared to the previous year. However, the total revenue remained flat since the last quarter at $1.26 billion.

The net income for FHN was reported at $897.00 million for the past year, showing no change since the previous year. However, there was a notable increase of 34.31% in net income since the last quarter, reaching $184.00 million.

Furthermore, the earnings per share (EPS) for FHN were $1.54 for the past year, which remained unchanged from the previous year. However, there was a substantial increase of 36.51% in EPS since the last quarter, reaching $0.31.

Overall, FHN stock demonstrated positive growth in net income and EPS since the last quarter, indicating a strong performance in the financial aspect. The increase in total revenue since the previous year also reflects the company’s ability to generate more revenue over time.

Investors and analysts may view these financial indicators as positive signs for FHN stock, suggesting potential growth and profitability in the future. It is essential to monitor the company’s financial performance continuously to make informed investment decisions based on the latest data and market trends.

Tags: FHN
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Technology Data analytics Stock Exchange

Elon Musk Endorses Fallout Series at SXSW Event

Biotechnology Trading online

Entera Bios Fiscal Year 2023 Financial Highlights and Cost Management Strategy

Technology Blockchain Markets and money

Title Ainos Inc Reports Significant Drop in Revenue for Fiscal Year 2023

Recommended

OHI stock news

Bel Fuse Director Sells 56700 Worth of Shares Amid Financial Challenges

2 years ago
I-Mab Stock

NovaBridge Biosciences Unveils Promising Clinical Trial Data and Strategic Rebranding

5 months ago
Nvidia Stock

Nvidia’s Key Supplier Signals Unwavering AI Demand

2 months ago
Silber Stock

Silver’s Perfect Storm: A Market Poised for Breakout

6 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Trending

SOXX ETF Stock
Commodities

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

by Kennethcix
March 25, 2026
0

The semiconductor industry finds itself navigating a complex landscape where geopolitical developments intersect with tangible supply chain...

Fair Isaac Stock

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
BioNano Genomics Stock

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026
Humacyte Stock

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns
  • Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance
  • Figma Embraces Third-Party AI to Power Its Design Ecosystem

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com